MR-guided facet joint injection therapy using an open 1.0-T MRI system: an outcome study

To evaluate the accuracy, safety and efficacy of magnetic resonance imaging (MRI)-guided facet joint injection therapy using a 1.0-T open MRI. One hundred and sixty-six facet joint blocks in 45 patients with lower back pain were performed under MR fluoroscopic guidance using a proton-density-weighted turbo-spin-echo sequence. An in-room monitor, wireless MR-mouse for operator-controlled multiplanar navigation, a flexible surface coil and MR-compatible 20-G needle were used. Clinical outcome was evaluated by questionnaire before intervention and after 1 week, 3, 6 and 12 months using a numerical visual analogue scale (VAS). All facet joint blocks were considered technically successful with distribution of the injectant within and/or around the targeted facet joint. No major complications occurred. The final outcome analysis included 38 patients. An immediate effect was reported by 63 % of the patients. A positive mid-/long-term effect was seen in 13 patients (34 %) after 6 months and in 9 patients (24 %) after 12 months. Mean VAS was reduced from 7.1 +/- 1.7 (baseline) to 3.5 +/- 2.2, 4.1 +/- 3.0, 3.8 +/- 2.9 and 4.6 +/- 2.9 at 1 week, 3, 6 and 12 months (P < 0.01). MR-guided facet joint injection therapy of the lumbosacral spine is accurate, safe and efficient in the symptomatic treatment of lower back pain. aEuro cent MR-guided facet joint infiltration provides an alternative to CT and conventional fluoroscopy. aEuro cent Clinical outcomes are comparable with conventional fluoroscopy and CT-guided facet joint interventions. aEuro cent Ionising radiation can be avoided for both patient and physician. aEuro cent MR-guided facet joint injection provides safe and effective treatment of back pain.